PHAT
Phathom Pharmaceuticals (PHAT)
$
90About Phathom Pharmaceuticals (PHAT)
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
Details
Daily high
$7.25
Daily low
$6.71
Price at open
$7.15
52 Week High
$19.71
52 Week Low
$6.06
Market cap
471.8M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
950,364
P/E ratio
-1.21
Phathom Pharmaceuticals News
Details
Daily high
$7.25
Daily low
$6.71
Price at open
$7.15
52 Week High
$19.71
52 Week Low
$6.06
Market cap
471.8M
Dividend yield
0.00%
Volume
1.1M
Avg. volume
950,364
P/E ratio
-1.21